Dr. Julia Romanova, PhD, DSc, is a virologist with more than 30 years of experience in influenza research and vaccine development. She began her career at the Institute of Experimental Medicine in St. Petersburg, Russia, working on live attenuated, cold-adapted influenza vaccines. Her research experience includes work at the University of Newcastle in Australia and the University of Natural Resources and Life Sciences in Vienna, Austria. At Green Hills Biotechnology GmbH in Austria, she contributed to the development of a new generation of replication-deficient intranasal influenza vaccines. She currently serves as a scientific consultant at Capricorn Technologies GmbH in Vienna, Austria, where she is involved in developing a live influenza vaccine based on the recombinant UniFluVec vector. Her research focuses on influenza virus biology, mechanisms of attenuation, and live influenza vaccine development.